Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial - Slebos, D-J; Shah, P L; Herth, F JF (Am J Respir Crit Care Med, 2019)
et al.